Karla I. AriasDr. sc. nat.

Counsel | Dr. sc. nat. | She/Her/Hers

Overview

Karla I. Arias, D.Sc., focuses her practice on patent and trade secret litigation and prosecuting patents for chemical and pharmaceutical clients. 

Before joining Crowell & Moring, Karla was a postdoctoral fellow at Carnegie Mellon University, where her research focused on investigating the degradation of endocrine-disrupting contaminants in water and the formation and reactivity of iron complexes. 

Karla received her doctorate in organic chemistry at the University of Zurich, where her research focused on the synthesis of supramolecular architectures and the study of fluorescent and phosphorescent properties of supramolecular building blocks.

Career & Education

|
    • University of California, San Diego, B.S., chemistry, 2004
    • University of Zurich, M.Sc., chemistry, 2006
    • University of Zurich, Dr. sc. nat., organic chemistry, 2011
    • George Mason University, J.D., 2018
    • University of California, San Diego, B.S., chemistry, 2004
    • University of Zurich, M.Sc., chemistry, 2006
    • University of Zurich, Dr. sc. nat., organic chemistry, 2011
    • George Mason University, J.D., 2018
    • District of Columbia
    • U.S. Patent and Trademark Office (USPTO)
    • District of Columbia
    • U.S. Patent and Trademark Office (USPTO)
  • Professional Activities and Memberships

    • HNBA/Microsoft Intellectual Property Law Institute (IPLI) Fellow

    Professional Activities and Memberships

    • HNBA/Microsoft Intellectual Property Law Institute (IPLI) Fellow

Karla's Insights

Client Alert | 3 min read | 02.21.24

Federal Circuit Hints at the Scope of Government’s License Rights

The Federal Circuit’s decision in University of South Florida Board of Trustees v. United States, 22-2248 (Fed. Cir. Feb. 9, 2024) hints at the broad scope of the federal government’s license rights under the Bayh-Dole Act. ...

Representative Matters

  • Waters Tech., Inc. & Waters Corp., Inc. v. Agilent Techs., Inc., No. 18-1450-MN (D. Del.)– Representing Agilent in a patent infringement suit on N-glycan labeling reagent.
  • Secured a significant victory (a preliminary injunction against patent infringement through trial) on behalf of Lonza Walkersville, Inc. against Israel-based Adva Biotechnology Ltd. in a case involving point-of-care cell-therapy technology.

Karla's Insights

Client Alert | 3 min read | 02.21.24

Federal Circuit Hints at the Scope of Government’s License Rights

The Federal Circuit’s decision in University of South Florida Board of Trustees v. United States, 22-2248 (Fed. Cir. Feb. 9, 2024) hints at the broad scope of the federal government’s license rights under the Bayh-Dole Act. ...

|

Karla's Insights

Client Alert | 3 min read | 02.21.24

Federal Circuit Hints at the Scope of Government’s License Rights

The Federal Circuit’s decision in University of South Florida Board of Trustees v. United States, 22-2248 (Fed. Cir. Feb. 9, 2024) hints at the broad scope of the federal government’s license rights under the Bayh-Dole Act. ...